[Neonatal chronic lung disease]

L V Silva Filho1

  • 1Universidade de São Paulo (USP), São Paulo, SP, Brazil.

Jornal De Pediatria
|December 20, 2003
PubMed

Insights

Neonatal chronic lung disease (CLD) is increasingly common in preterm infants. Management requires individualized treatment and crucial outpatient follow-up, addressing nutritional and social needs for better outcomes.

Area of Science:

  • Neonatology
  • Pediatric Pulmonology

Background:

  • Chronic lung disease (CLD) in neonates is a growing concern due to improved survival rates of preterm infants.
  • Understanding the pathophysiology of neonatal CLD is critical, with prematurity and respiratory support being key factors.

Purpose of the Study:

  • To review the pathophysiology and outpatient follow-up of neonatal chronic lung disease.
  • To highlight the complexities in diagnosis and management of this condition.

Main Methods:

  • A comprehensive Medline search was conducted for relevant articles on neonatal chronic lung disease since its initial description in 1967.
  • Review of existing literature to synthesize information on pathophysiology, treatment, and follow-up.

Main Results:

  • Neonatal CLD incidence is rising, driven by increased survival of premature infants.
  • Pathophysiology involves prematurity and respiratory assistance; treatment is complex and individualized, with controversial drug indications.
  • Essential outpatient follow-up must encompass nutritional and social aspects for optimal prognosis.

Conclusions:

  • Neonatal CLD is often under-recognized by pediatricians, especially concerning post-discharge care.
  • Severe cases necessitate specialized centers with advanced resources.
  • Prognosis varies widely, influenced by prematurity complications and timely intervention.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...